MRES Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.00 - $0.03
Previous CloseN/A
Volume700.00K
Average Volume (3M)395.50K
Market Cap
$4.95M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,749,320,800
10 Day Avg. Volume485,322
30 Day Avg. Volume395,505
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MRES FAQ
What was Institute of Biomedical Research Corp’s price range in the past 12 months?
Institute of Biomedical Research Corp lowest stock price was $0.00 and its highest was $0.03 in the past 12 months.
What is Institute of Biomedical Research Corp’s market cap?
Institute of Biomedical Research Corp’s market cap is $4.95M.
When is Institute of Biomedical Research Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Institute of Biomedical Research Corp’s earnings last quarter?
Currently, no data Available
Is Institute of Biomedical Research Corp overvalued?
According to Wall Street analysts Institute of Biomedical Research Corp’s price is currently Overvalued.
Does Institute of Biomedical Research Corp pay dividends?
Institute of Biomedical Research Corp does not currently pay dividends.
What is Institute of Biomedical Research Corp’s EPS estimate?
Institute of Biomedical Research Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Institute of Biomedical Research Corp have?
Institute of Biomedical Research Corp has 2,749,320,800 shares outstanding.
What happened to Institute of Biomedical Research Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Institute of Biomedical Research Corp?
Currently, no hedge funds are holding shares in MRES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Institute of Biomedical Research Corp
Institute of Biomedical Research Corp. (MRES) is a dedicated provider of comprehensive biomedical research and analytical services, operating both within Montenegro and across international markets. The company's core activities encompass fundamental scientific investigation and robust research and development initiatives for new biomedical products, advanced technologies, and innovative diagnostic methods, including experimental medical treatments. MRES also focuses on the creation of novel biomedical and food products. A significant part of its mandate involves regulatory oversight of industrial activities and their associated products, alongside scientific environmental monitoring. Furthermore, it delivers expert regulatory evaluation and certification services for a wide array of biomedical products. The institute also contributes to academic advancement through graduate research study programs in the biomedical and environmental fields. MRES manufactures and supplies a diverse range of healthcare devices. Its offerings include two-channel analog NMS units, various digital muscle stimulators, digital TENS devices, interferential therapy units, elite combination models, portable four-channel digital stimulators, and portable ultrasound equipment. The product portfolio also extends to photon red light devices for aesthetic applications, electric pain relief solutions, microcurrent electrical nerve stimulators, and high-volt pulsed stimulators. The company excels in the development and commercialization of specialized agents and products. This category features microbicidal agents, a variety of disinfectant solutions, and specialized medical supplies such as bandages tailored for severe burns. They also provide products for hard surface disinfection, microbicidal treatments for fabrics and textiles, insecticides (including those targeting bed bugs), microbicidal towels, and mouthwash. Key innovations include Purilair, an apparatus specifically designed for sterilizing compressed air within medical instruments, alongside colloidal silver and other electro-medical devices. A notable product is BioStim INF, which is engineered for reducing edema, alleviating pain, and delivering comprehensive therapeutic benefits. Beyond its product and research endeavors, MRES offers a broad spectrum of essential services. These include quality control, regulatory assistance, healthcare support, environmental analysis, building decontamination, and extensive environmental protection and management services. They are also a critical source for regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was established in 2010 and maintains its headquarters in Podgorica, Montenegro, with a representative office located in Montreal, Canada, facilitating its global operations.
Technical Analysis
Moleculin Biotech
―
Propanc Biopharma
―
Genprex
―
Creative Medical Technology Holdings
―
Onconetix
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors